+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Product Type (Marijuana, Hemp), By Application (Medical Use, Industrial Use), And Segment Forecasts, 2021 - 2028

  • ID: 5450192
  • Report
  • September 2021
  • Region: Australia
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • BOD AUSTRALIA
  • CANN GROUP LIMITED
  • ECOFIBRE
  • MGC PHARMACEUTICALS LTD.
  • ZELIRA THERAPEUTICS
The Australia legal cannabis market size is expected to reach USD 375.7 million by 2028, according to a new report by the publisher The market is expected to expand at a CAGR of 32.7% from 2021 to 2028. The increasing legalization of cannabis, rising patient population, increasing government support, and the availability of local and international players in the country are some of the major factors boosting the country’s growth. In addition, the surge in medical marijuana production owing to its increasing demand in the pharmaceutical sector is further propelling overall growth. The COVD-19 pandemic has negatively impacted the country’s growth rate due to supply chain restrictions imposed due to nationwide lockdown.





As of 2020, the hemp product type segment held the largest revenue share. The market growth is attributed to the rising adoption of hemp-based products for various medical and industrial purposes. The increasing prevalence of epilepsy and other sleep disorders is aiding the product adoption thereby, positively contributing to the segment growth. On the other hand, the marijuana segment is anticipated to be the fastest-growing segment during the forecast period owing to the increasing legalization of these products for medical and adult use and increasing consumer shift towards purchasing the product through legal channels.

The industrial application segment accounted for the majority share in 2020. Growing demand for hemp fibers and oil in the construction, food and beverage, personal care, automotive, and textile industries is aiding segment growth. On the other hand, the medical application segment is expected to be the fastest-growing segment during the forecast period owing to awareness regarding health benefits offered by cannabis products for various medical applications, including anxiety, chronic pain, sleep disorder, and inflammation.

Australia Legal Cannabis Market Report Highlights

  • The market is expected to grow well by 2028 owing to the increasing legalization of cannabis in the country
  • The hemp product type segment dominated the market in 2020 due to the increasing adoption of hemp-based products
  • The industrial application segment dominated the market in 2020 owing to increasing demand for hemp-based products for various industrial purposes


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Australian Legal Cannabis Market

What is the estimated value of the Australian Legal Cannabis Market?

The Australian Legal Cannabis Market was estimated to be valued at $41.2 Million in 2020.

What is the growth rate of the Australian Legal Cannabis Market?

The growth rate of the Australian Legal Cannabis Market is 32.7%, with an estimated value of $375.7 Million by 2028.

What is the forecasted size of the Australian Legal Cannabis Market?

The Australian Legal Cannabis Market is estimated to be worth $375.7 Million by 2028.

Who are the key companies in the Australian Legal Cannabis Market?

Key companies in the Australian Legal Cannabis Market include AUSCANN GROUP HOLDINGS LTD., CANN GROUP LIMITED, BOD AUSTRALIA, ZELIRA THERAPEUTICS, ALTHEA COMPANY PTY LIMITED, THC GLOBAL GROUP LTD. (EPSILON HEALTHCARE) and ECOFIBRE.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BOD AUSTRALIA
  • CANN GROUP LIMITED
  • ECOFIBRE
  • MGC PHARMACEUTICALS LTD.
  • ZELIRA THERAPEUTICS

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Research Methodology
1.2.1 Information Procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.4.1 Country Market: CAGR Calculation
1.5 Research Methodology
1.6 Country Based Segment Share Calculation
1.7 List of Secondary Sources
1.8 List of Primary Sources
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Segment Summary
2.3 Competitive Analysis
Chapter 3 Australia Legal Cannabis Market: Variables, Trends & Scope
3.1 Penetration & Growth Prospects Mapping
3.2 Australia Legal Cannabis: Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rising Patient Population
3.2.1.2 Growing Legalization Of Cannabis-Based CBD Products
3.2.1.3 Entry Of International Players
3.2.2 Market Restraint Analysis
3.2.2.1 Stringent Regulations
3.2.2.2 Illicit Cannabis Trade
3.2.3 Industry Challenge
3.2.3.1 Lower market access to cannabis due to absence of legalization programs, leading to smuggling
3.2.3.2 Incomplete evidence regarding the effectiveness of medical marijuana
3.3 Regulatory Scenario
3.3.1 Australia
3.3.1.1 Overview
3.3.1.2 Cultivation
3.3.1.3 Regulatory Bodies Involved
3.3.1.4 Import/Export Scenario
3.4 Industry Analysis – SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.4.1 Political And Legal Landscape
3.4.2 Economic And Social Landscape
3.4.3 Technology Landscape
3.5 Industry Analysis – Porter’s Analysis
3.5.1 Threat Of New Entrants - Moderate
3.5.2 Bargaining Power Of Buyers - Low
3.5.3 Bargaining Power Of Suppliers-Moderate
3.5.4 Threat Of Substitutes-Moderate
3.5.5 Competitive Rivalry-High
3.6 Opportunity Analysis
3.7 Value Chain Analysis
3.7.1 Raw Material Trends
3.7.1.1 Market Price Evolution Of Biomass Commodity Cost (To Processor)
3.7.1.2 Manufacturing Trends
3.8 Australia Legal Cannabis User Pool
3.8.1 Estimated Number Of Cannabis Users In Australia From 2016 To 2028
Chapter 4 Australia Legal Cannabis Market: Product Type Estimates & Trend Analysis
4.1 Australia Legal Cannabis Market: Product Type Movement Analysis
4.1.1 Australia Legal Cannabis Market: Product Type Movement Analysis (2020 & 2028)
4.1.2 Hemp
4.1.2.1 Hemp market estimates and forecasts, 2016 - 2028 (USD Million)
4.1.2.2 Hemp CBD
4.1.2.2.1 Hemp CBD market estimates and forecasts, 2016 - 2028 (USD Million)
4.1.2.3 Supplements
4.1.2.3.1 Supplements market estimates and forecasts, 2016 - 2028 (USD Million)
4.1.2.4 Industrial Hemp
4.1.2.4.1 Industrial hemp market estimates and forecasts, 2016 - 2028 (USD Million)
4.1.3 Marijuana
4.1.3.1 Marijuana market estimates and forecasts, 2016 - 2028 (USD Million)
4.1.3.2 Flower
4.1.3.2.1 Flower market estimates and forecasts, 2016 - 2028 (USD Million)
4.1.3.3 Oil & Tinctures
4.1.3.3.1 Oil & tinctures market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 5 Australia Legal Cannabis Market: Application Estimates & Trend Analysis
5.1 Australia Legal Cannabis Market: Application Movement Analysis
5.1.1 Medical Use
5.1.1.1 Medical use market estimates and forecasts, 2016 - 2028 (USD Million)
5.1.1.2 Chronic Pain
5.1.1.2.1 Chronic pain market estimates and forecasts, 2016 - 2028 (USD Million)
5.1.1.3 Anxiety
5.1.1.3.1 Anxiety market estimates and forecasts, 2016 - 2028 (USD Million)
5.1.1.4 Inflammation
5.1.1.4.1 Inflammation market estimates and forecasts, 2016 - 2028 (USD Million)
5.1.1.5 Sleep Disorders
5.1.1.5.1 Sleep disorders market estimates and forecasts, 2016 - 2028 (USD Million)
5.1.1.6 Others
5.1.1.6.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
5.1.2 Industrial Use
5.1.2.1 Industrial use market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles: ASX Listed Cannabis Companies
6.1.1 AUSCANN GROUP HOLDINGS LTD.
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product Benchmarking
6.1.1.4 Strategic initiatives
6.1.2 CANN GROUP LIMITED
6.1.2.1 Company overview
6.1.2.2 Product Benchmarking
6.1.2.3 Financial performance
6.1.2.4 Strategic initiatives
6.1.3 BOD AUSTRALIA
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Benchmarking
6.1.3.4 Strategic Initiatives
6.1.4 ZELIRA THERAPEUTICS
6.1.4.1 Company Overview
6.1.4.2 Product Benchmarking
6.1.4.3 Strategic Initiatives
6.1.5 ALTHEA COMPANY PTY LIMITED
6.1.5.1 Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Product Benchmarking
6.1.5.4 Strategic Initiatives
6.1.6 THC GLOBAL GROUP LTD. (EPSILON HEALTHCARE)
6.1.6.1 Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Product Benchmarking
6.1.6.4 Strategic Initiatives
6.1.7 MGC PHARMACEUTICALS LTD.
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 PRODUCT BENCHMARKING
6.1.7.4 Strategic Initiatives
6.1.8 ECOFIBRE
6.1.8.1 Company Overview
6.1.8.2 Financial Performance
6.1.8.3 Product Benchmarking
6.1.8.4 Strategic Initiatives
List of Tables
Table 1 List of secondary data sources
Table 2 List of primary sources
Table 3 Estimated number of cannabis users, 2016 - 2028
Table 4 Australia legal cannabis market, by product type, 2016 - 2028 (USD Million)
Table 5 Australia marijuana market, by product, 2016 - 2028 (USD Million)
Table 6 Australia hemp market, by product, 2016 - 2028 (USD Million)
Table 7 Australia legal cannabis market, by application, 2016 - 2028 (USD Million)
Table 8 Australia legal cannabis medical application market, by application, 2016 - 2028 (USD Million)
List of Figures
Figure. 1 Market segmentation
Figure. 2 Market research process
Figure. 3 Information procurement
Figure. 4 Primary research pattern
Figure. 5 Market research approaches
Figure. 6 Value chain-based sizing & forecasting
Figure. 7 QFD modelling for market share assessment
Figure. 8 Market formulation & validation
Figure. 9 Australia legal cannabis market snapshot, 2020 (USD Million)
Figure. 10 Penetration & growth prospects mapping
Figure. 11 Australia legal cannabis market driver impact
Figure. 12 Australia legal cannabis market restraint impact
Figure. 13 Opportunity analysis
Figure. 14 Australia legal cannabis market, product type outlook: Key takeaways
Figure. 15 Australia legal cannabis market: Product type movement analysis (2020 & 2028) (USD Million)
Figure. 16 Hemp market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 17 Hemp CBD market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 18 Supplements market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 19 Industrial hemp market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 20 Marijuana market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 21 Flower market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 22 Oil & tinctures market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 23 Australia legal cannabis market, application outlook: Key takeaways
Figure. 24 Australia legal cannabis market: Application movement analysis (2019 & 2028)
Figure. 25 Medical use market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 26 Chronic pain market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 27 Anxiety market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 28 Inflammation market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 29 Sleep Disorders market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 30 Others market estimates and forecasts, 2016 - 2028 (USD Million)
Figure. 31 Industrial use market estimates and forecasts, 2016 - 2028 (USD Million)
Note: Product cover images may vary from those shown
  • AUSCANN GROUP HOLDINGS LTD.
  • CANN GROUP LIMITED
  • BOD AUSTRALIA
  • ZELIRA THERAPEUTICS
  • ALTHEA COMPANY PTY LIMITED
  • THC GLOBAL GROUP LTD. (EPSILON HEALTHCARE)
  • MGC PHARMACEUTICALS LTD.
  • ECOFIBRE
Note: Product cover images may vary from those shown

Loading
LOADING...